NSE BSE
godavari drugs ltd. stock

GODAVARI DRUGS LTD. Share Price

- - (%)
- NSE: GODAVARI

GODAVARI DRUGS LTD. Share Price Update

As of the latest trading session, GODAVARI DRUGS LTD. share price is currently at 102.4, which is down by -3.65 from its previous closing. Today, the stock has fluctuated between 101.40 and 106.75. Over the past year, GODAVARI DRUGS LTD. has achieved a return of 9.04 %. In the last month alone, the return has been 2.73 %. Read More...

GODAVARI DRUGS LTD. Performance

Day Range

Low101.40 High106.75
102.40

52 Week Range

Low 82.10 High 114.00
102.40

GODAVARI DRUGS LTD. Share Price

530317

GODAVARI

img img img img
No Data Available

Open Price

105.00

Prev. Close

106.05

Volume (Shares)

13853.00

Total traded value

14.21

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

GODAVARI DRUGS LTD. Fundamentals


(Standalone)

Market Cap (Cr) 77.10
PE Ratio (TTM) 13.89
Book Value / Share 51.75
Beta 0.21
ROE 12.02%
EPS (TTM) 7.47
Dividend Yield 0.00%
Net Profit Qtr (Cr) 2.66

GODAVARI DRUGS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 38.64
Operating Expense 35.93
Net Profit 2.66
Net Profit Margin (%) 6.88
Earnings Per Share (EPS) 3.53
EBITDA 4.55
Effective Tax Rate (%) 4.65
Particulars DEC 2023 (Values in Cr)
Revenue 43.11
Operating Expense 41.36
Net Profit 1.22
Net Profit Margin (%) 2.82
Earnings Per Share (EPS) 1.62
EBITDA 3.51
Effective Tax Rate (%) 29.88
Particulars SEP 2023 (Values in Cr)
Revenue 39.54
Operating Expense 38.26
Net Profit 0.86
Net Profit Margin (%) 2.17
Earnings Per Share (EPS) 1.14
EBITDA 3.06
Effective Tax Rate (%) 33.07
Particulars JUN 2023 (Values in Cr)
Revenue 35.42
Operating Expense 34.75
Net Profit 0.81
Net Profit Margin (%) 2.28
Earnings Per Share (EPS) 1.08
EBITDA 2.70
Effective Tax Rate (%) 27.67
Particulars MAR 2023 (Values in Cr)
Revenue 37.37
Operating Expense 36.21
Net Profit 1.33
Net Profit Margin (%) 3.55
Earnings Per Share (EPS) 1.77
EBITDA 3.07
Effective Tax Rate (%) 13.63
Particulars MAR 2024 (Values in Cr)
Revenue 156.71
Operating Expense 150.32
Net Profit 5.55
Net Profit Margin (%) 3.54
Earnings Per Share (EPS) 7.37
EBITDA 13.83
Effective Tax Rate (%) 19.79
Particulars MAR 2023 (Values in Cr)
Revenue 159.62
Operating Expense 155.58
Net Profit 3.79
Net Profit Margin (%) 2.37
Earnings Per Share (EPS) 5.03
EBITDA 10.79
Effective Tax Rate (%) 23.32
Particulars MAR 2022 (Values in Cr)
Revenue 161.11
Operating Expense 154.35
Net Profit 5.25
Net Profit Margin (%) 3.25
Earnings Per Share (EPS) 6.97
EBITDA 11.56
Effective Tax Rate (%) 25.35
Particulars MAR 2021 (Values in Cr)
Revenue 122.67
Operating Expense 117.38
Net Profit 4.13
Net Profit Margin (%) 3.36
Earnings Per Share (EPS) 5.48
EBITDA 10.24
Effective Tax Rate (%) 27.67
Particulars MAR 2020 (Values in Cr)
Revenue 95.70
Operating Expense 93.74
Net Profit 2.00
Net Profit Margin (%) 2.08
Earnings Per Share (EPS) 2.66
EBITDA 6.36
Effective Tax Rate (%) 12.66
Particulars MAR 2023 (Values in Cr)
Book Value / Share 44.38
ROE % 12.02
ROCE % 14.37
Total Debt to Total Equity 0.93
EBITDA Margin 6.77
Particulars MAR 2022 (Values in Cr)
Book Value / Share 39.35
ROE % 19.44
ROCE % 18.12
Total Debt to Total Equity 0.99
EBITDA Margin 7.18
Particulars MAR 2021 (Values in Cr)
Book Value / Share 32.38
ROE % 18.50
ROCE % 17.34
Total Debt to Total Equity 1.30
EBITDA Margin 8.36
Particulars MAR 2020 (Values in Cr)
Book Value / Share 26.90
ROE % 10.22
ROCE % 11.55
Total Debt to Total Equity 1.29
EBITDA Margin 6.65
Particulars MAR 2019 (Values in Cr)
Book Value / Share 24.24
ROE % 6.41
ROCE % 11.59
Total Debt to Total Equity 1.17
EBITDA Margin 6.85
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.08
Total Assets 121.43
Total Liabilities 121.43
Total Equity 33.41
Share Outstanding 7530500
Price to Book Ratio 1.71
Return on Assets (%) 3.11
Return on Capital (%) 5.66
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.27
Total Assets 101.41
Total Liabilities 101.41
Total Equity 29.63
Share Outstanding 7530500
Price to Book Ratio 1.66
Return on Assets (%) 5.17
Return on Capital (%) 10.5
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.63
Total Assets 91.13
Total Liabilities 91.13
Total Equity 24.38
Share Outstanding 7530500
Price to Book Ratio 1.41
Return on Assets (%) 4.52
Return on Capital (%) 7.87
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.42
Total Assets 83.91
Total Liabilities 83.91
Total Equity 20.25
Share Outstanding 7530500
Price to Book Ratio 0.43
Return on Assets (%) 2.38
Return on Capital (%) 4.32
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 1.52
Total Assets 73.73
Total Liabilities 73.73
Total Equity 18.25
Share Outstanding 7530500
Price to Book Ratio 0.96
Return on Assets (%) 1.63
Return on Capital (%) 3.08
Particulars MAR 2023 (Values in Cr)
Net Income 10.80
Cash from Operations 14.36
Cash from Investing -8.63
Cash from Financing -3.77
Net change in Cash 0.80
Free Cash Flow 23.66
Particulars MAR 2022 (Values in Cr)
Net Income 11.56
Cash from Operations 13.00
Cash from Investing -4.97
Cash from Financing -5.62
Net change in Cash 0.63
Free Cash Flow 18.25
Particulars MAR 2021 (Values in Cr)
Net Income 10.23
Cash from Operations 2.90
Cash from Investing -1.25
Cash from Financing 0.13
Net change in Cash 0.21
Free Cash Flow 4.57
Particulars MAR 2020 (Values in Cr)
Net Income 6.36
Cash from Operations 6.63
Cash from Investing -6.68
Cash from Financing 0.33
Net change in Cash -0.09
Free Cash Flow 13.52
Particulars MAR 2019 (Values in Cr)
Net Income 5.72
Cash from Operations 3.99
Cash from Investing -2.33
Cash from Financing -1.46
Net change in Cash -0.09
Free Cash Flow 6.57
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 110.15 12.05 1.19 1155.28 77.65 / 148.95
CIPLA LTD 1485.15 28.17 4.49 119928.54 1028.00 / 1581.70
FERMENTA BIOTECH LIMITED 229.35 0.00 2.33 675.00 137.10 / 262.00
GLAXOSMITHKLINE PHARMA LT 2570.70 66.32 24.49 43549.21 1376.50 / 2759.00
SANOFI INDIA LIMITED 6357.65 25.81 14.42 14641.67 5850.55 / 10526.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
GODAVARI DRUGS LTD. 102.40 13.71 1.97 77.11 82.10 / 114.00
AMRUTAJAN HEALTH LTD 738.70 47.47 7.40 2135.63 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6349.65 106.48 22.29 15874.13 3730.00 / 7550.00
BLISS GVS PHARMA LTD 110.15 15.17 1.16 1155.28 77.65 / 148.95
ABBOTT INDIA LIMITED 27407.65 48.49 15.74 58241.26 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 104.20
  • 26 Days 102.50
  • 10 Days 104.00
  • 50 Days 100.10
  • 12 Days 104.10
  • 100 Days 99.70
  • 20 Days 103.00
  • 200 Days 96.30
106.22
PIVOT
First Resistance 107.73
Second Resistance 109.42
Third Resistance 110.93
First Support 104.53
Second Support 103.02
Third Support 101.33
RSI 53.34
MACD 1.57
Commodity Channel Index (CCI) 13.75
ADX 39.83
Williams % R -80.69

Over 1 Month

down

2.73

Over 3 Months

down

3.42

Over 6 Months

down

-0.26

Over 1 Year

down

9.04

Over 3 Years

down

9.92

Over 5 Years

down

39.62

GODAVARI DRUGS LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

GODAVARI DRUGS LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
46.84
Promoter Holdings
53.15
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
1.25
Name Category Shares Shares%
Sushma Kakani Shareholding of Promoter and Promoter Group 1155000.0 15.34
Kamala Jaju Shareholding of Promoter and Promoter Group 910000.0 12.08
Mohit Jaju Shareholding of Promoter and Promoter Group 535000.0 7.1
Ghanshyam Jaju Shareholding of Promoter and Promoter Group 350000.0 4.65
Mukund Kakani Shareholding of Promoter and Promoter Group 350000.0 4.65
Aksheit Kakani Shareholding of Promoter and Promoter Group 326000.0 4.33
Highcrestt Global Company Ltd Public Shareholding 200000.0 2.66
Priyanka Jaju Shareholding of Promoter and Promoter Group 185000.0 2.46
Tanushree Kakani Shareholding of Promoter and Promoter Group 140000.0 1.86
Gautam Chand Jain Public Shareholding 109000.0 1.45
Umesh Kumar Gupta Public Shareholding 107242.0 1.42
Swet Realtors Pvt. Ltd. Public Shareholding 100000.0 1.33
Varun Jain Public Shareholding 90000.0 1.2
Gopalakrishnan. V. Public Shareholding 89500.0 1.19
Kirti Kumar Jain Shareholding of Promoter and Promoter Group 50000.0 0.66
Jaju Ghanshyam Huf Shareholding of Promoter and Promoter Group 2200.0 0.03
Prashant Shrimal Shareholding of Promoter and Promoter Group 0.0 0.0

GODAVARI DRUGS LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About GODAVARI DRUGS LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by GODAVARI DRUGS LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Godavari Drugs Ltd?

Answer Field

The share price of Godavari Drugs Ltd for NSE is ₹ 0.00 and for BSE is ₹ 102.40.

What is the Market Cap of Godavari Drugs Ltd?

Answer Field

The market cap of Godavari Drugs Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 77.10 Cr. as of now.

What is the 52 Week High and Low of Godavari Drugs Ltd?

Answer Field

The 52 Week High and Low of Godavari Drugs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 114.00 and ₹ 82.10.

How to Buy Godavari Drugs Ltd share?

Answer Field

You can trade in Godavari Drugs Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Godavari Drugs Ltd?

Answer Field

The 1 year returns on the stock has been 9.04%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader